1. Comparative analysis of monoclonal antibodies against prostate‐specific membrane antigen (PSMA). Issue 16 (27th September 2014) Authors: Tykvart, J.; Navrátil, V.; Sedlák, F.; Corey, E.; Colombatti, M.; Fracasso, G.; Koukolík, F.; Bařinka, C.; Šácha, P.; Konvalinka, J. Journal: Prostate Issue: Volume 74:Issue 16(2014) Page Start: 1674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of serum response factor as a new strategy to overcome resistance to enzalutamide in prostate cancer. (October 2020) Authors: Watson, W.; Gonzalez, C.; Russell, N.; Azam, H.; Corey, E.; Morrissey, C.; Gallagher, W.; Prencipe, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting neuroendocrine prostate cancer using a novel human antibody construct. (December 2016) Authors: LeBeau, A.; Lang, S.; Zhou, H.; Corey, E.; Morrissey, C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗